HUTCHMED (NASDAQ:HCM) reported positive results from its 338-patient Phase III SAFFRON lung cancer trial, showing that ORPATHYS plus TAGRISSO significantly improved survival compared with platinum-based chemotherapy.
Bristol Myers Squibb (NYSE:BMY) and SystImmune reported positive Phase 3 PANKU-Lung01 results showing that izalontamab brengitecan extended median progression-free survival to 11.1 months in previously treated EGFR-mutated non-small cell lung cancer.
The European Central Bank (ECB) could launch the digital euro as early as 2029, subject to EU legislative approval, according to an interview with ECB Executive Board member Piero Cipollone published by Milano Finanza.
Pinnacle Minerals (ASX:PIM) has entered into a binding agreement to acquire APT Tungsten, securing rights to five tungsten projects in Utah.
Invex Therapeutics (ASX:IXC) has entered into a binding agreement to acquire 100% of New Zealand biotechnology firm Rekover Therapeutics.
Phantom is rolling out Kalshi event contracts to US users through its app, according to an exclusive report by The Block.
Marmota (ASX:MEU) reported new drill results from its Greenewood programme that double the known strike length of high-grade gold to over 2km.
CZR Resources (ASX:CZR) will seek regulatory consent to withdraw its off-market takeover bid for Zuleika Gold (ASX:ZAG) after shareholders rejected key acquisition resolutions.
AML3D (ASX:AL3) secured an initial ~$2.2 million order for a large-scale ARCEMY X system from US Navy prime contractor Northrop Grumman Marine Systems.
Beforepay Group (ASX:B4P) lifted first-quarter revenue 45% year-on-year to a record $16.5 million.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
